-+ 0.00%
-+ 0.00%
-+ 0.00%
TempraMed Secures U.S. Patent for VIVI Cap Smart Injection Pen Platform
Share
Listen to the news
TempraMed Secures U.S. Patent for VIVI Cap Smart Injection Pen Platform
  • TempraMed secured a U.S. patent for its VIVI Cap Smart platform on September 29, 2026.
  • The patent covers thermal insulation and smart monitoring for the cap, which adapts to different injection pens.
  • The grant strengthens a global portfolio of 39 granted patents and registered designs across multiple jurisdictions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempramed Technologies Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611100700NEWSFILECNPR____20261110_323269_1) on November 10, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending